Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CapsoVision (CV) Cash & Equivalents (2024 - 2025)

CapsoVision (CV) has disclosed Cash & Equivalents for 2 consecutive years, with $10.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 8.51% to $10.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.1 million through Dec 2025, up 8.51% year-over-year, with the annual reading at $10.1 million for FY2025, 8.51% up from the prior year.
  • Cash & Equivalents hit $10.1 million in Q4 2025 for CapsoVision, down from $17.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $17.8 million in Q3 2025 to a low of $1.1 million in Q2 2025.